MTM. I. Tsarev

M. I. Tsarev

*This is an algorithmically generated author record based on publicly available information.

M. I. Tsarev has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Clinical and Laboratory Features of Infectious Complications in Patients with Mental and Behavioral Disorders

    by A. A. Anderzhanova, V. A. Mazus, S. V. Yakovlev, Yu. A. Meleshkina, M. I. Tsarev, M. V. Lukina, M. A. Balalaeva

    Background : the issues of diagnosis and prevalence of infectious complications (ICs) in patients with mental disorders remain insufficiently studied. Diagnosing ICs in this population is challenging due to poor patient cooperation, atypical presentation of infections, and masking of symptoms by the underlying psychiatric illness. Classical markers of infection are often non-specific or lack sensitivity, highlighting the need for more reliable diagnostic and prognostic criteria. The aim of study was to investigate the incidence and clinical-laboratory features of ICs in psychiatric patients to develop specialized algorithms for early diagnosis and treatment. Patients and Methods : a retrospective, non-interventional study was conducted based on the analysis of the “CLIOPS” database. The study included 727 patients (385 men and 342 women; mean age 62 ys), divided into two groups: without IC (n = 360) and with IC (n = 367). Anthropometric, demographic, clinical, and laboratory data were analyzed. Results : the most vulnerable group were patients with organic mental disorders (52.9% of all patients with ICs). The leading ICs were pneumonia (59.7%) and urinary tract infections (13.9%). Patients with IC had significantly more frequently: longer hospitalization, higher Waterlow scale scores, elevated CRP levels (99.2% vs 0.8%), leukocytosis (82.6% vs 55.8%), and changes in psychotic status (9.3% vs 1.7%). Fever was absent in 35.6% of patients with ICs. The strongest predictors of IC were: elevated CRP (OR = 50.2), fever > 38 °C (OR = 40.9), and altered mental status (OR = 6.02). Conclusion : diagnosing IC in patients with mental disorders requires a comprehensive approach due to the frequent absence of classic symptoms. The most significant markers of IC are elevated CRP and sudden decompensation of mental state. The lack of productive communication with the patient is a key factor complicating diagnosis. It is necessary to implement targeted screening algorithms for at-risk groups (patients with organic mental disorders), mandatorily including CRP testing and thorough assessment of mental state for early infection detection and therapy initiation.

  • Endovascular methods for prevention and treatment of upper gastrointestinal bleeding

    by A.V. Vasiliev, E.A. Antipov, E.S. An, M.I. Tsarev, A.A. Anderzhanova, Yu.A. Meleshkina, M.V. Lukina

    Objective. To analyze effectiveness and safety of transcatheter arterial embolization for the treatment of upper gastrointestinal bleeding and compare these results with national and international data. Material and methods. A retrospective analysis of local database included patients with gastroduodenal bleeding for the period from 08.2022 to 12.2024. There were 48 patients including 28 (58.3%) men and 20 (41.6%) women. Mean age of patients was 67.9±11.4 years. Own results were compared with national and international data. Results. There were the following causes of bleeding: various gastric and duodenal tumors — 30 (62.5%); acute and chronic gastric and duodenal ulcers — 16 (33.3%); erosive gastritis, esophagitis — 3 (6.25%). Primary inefficiency of endoscopic hemostasis was noted in 7 patients. In other 41 patients, endoscopic hemostasis was effective. Technical success rate was 100% (48 patients). Recurrence of bleeding was observed in 2 (4%) patients after 2 and 11 days. There was 1 complication (shoulder hematoma without necessary surgical correction). Mean hospital-stay was 15 days. Mortality rate was 33.3% (n=16); 32 (66.7%) patients were discharged. Conclusion. Transcatheter arterial embolization is a quick, safe and effective minimally invasive alternative to surgery, when endoscopic treatment does not allow upper gastrointestinal bleeding control. The advantages of arterial embolization are feasibility of this method in high risk patients, combination of diagnostic angiography to identify the cause of bleeding, rapid hemostasis compared to other instrumental methods.

  • Open Access

    Efficacy and safety of human albumin solutions in adult patients undergoing cardiac surgery

    by D. A. Reznik, D. A. Petrenko, L. V. Selivanova, M. A. Balalaeva, R. D. Komnov, A. A. Eremenko, A. A. Anderzhanova, Yu. A. Melyoshkina, M. I. Tsarev, M. V. Lukina, et al.

    Introduction . Human albumin (HA) solution is commonly used in cardiac surgery for hypovolemia correction, hemodynamic stabilization, and as a component of perfusion media. Despite its widespread use, the efficacy and safety of HA in cardiac surgery patients remain debated. Existing evidence is conflicting: some studies suggest potential benefits for hemodynamic control and renal function, while others show no significant advantage over crystalloids or synthetic colloids regarding key outcomes such as mortality and complication rates. The lack of unified clinical guidelines or algorithms for HA administration in the perioperative period, coupled with its high cost, underscores the need for a systematic review of current evidence to define clear and justified indications for its use in this specific patient population. The objective was to review the literature on the effectiveness and safety of using HA solutions in adult cardiac surgery patients Materials and methods . Based on the analysis of literature in the PubMed, Cochrane Library, eLibrary, Google Scholar databases, publications were selected with search restrictions on the following parameters: «people», «adults», «efficacy», «safety», «replenishment of CBV», «hypoalbuminemia », «intensive care», «surgical intervention», «cardiac surgery», «mortality», «survival». Results . According to the literature analysis, the use of HA solutions in cardiac surgery patients in the situation of hypovolemia correction and hemodynamic stabilization is justified. Preference should be given to isooncotic HA solution (4–5%). The administration of HA solution does not affect the frequency of postoperative complications, mortality, length of stay in the intensive care unit and hospital. Conclusions . The use of HA solutions in cardiac surgery patients requires an individual approach, assessment of the clinical condition and potential benefits of its physiological effects in certain clinical scenarios, however, additional randomized clinical studies comparing albumin 5% and albumin 20% in this population are needed for final conclusions.